The Ljungström family office co-led AnaCardio’s €62.5 million Series B alongside Novo Holdings and, two days earlier, came in as a new investor in Breye Therapeutics’ €67.5 million Series A. Two commitments of that size inside one week, in a therapeutic area as capital-hungry as clinical-stage biotech, is the kind of activity that usually belongs to ...
Click on the "Follow" button below and you'll get the latest news from Familyofficehub.io via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
Familyofficehub.io title: Home - familyofficehub.io